Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine (2022) / Chapter Skim
Currently Skimming:
Appendix C: Open Session Agendas
Appendix C: Open Session Agendas
Pages 353-366
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 353... ...
C Open Session Agendas September 22, 2020 CLOSED SESSION Full Schedule in Eastern Time 11:00–11:15 Welcome Guy Palmer, Committee Chair 11:15–12:45 Bias and Conflict of Interest Discussion Lauren Shern, Director of Policy, Health and Medicine Divi sion, National Academies of Sciences, Engineering, and Medicine 12:45–1:00 Review Statement of Task and Study Timeline Guy Palmer, Committee Chair 1:00–1:30 Framing the Report for Policy Makers Julie Eubank, Assistant Director, Congressional and Government Affairs, National Academies of Sciences, Engineering, and Medicine 1:30 Adjourn 353
|
From page 354... ...
Department of Agriculture (USDA) 12:40–1:05 NIH Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria Jane Knisely, Program Officer, Bacteriology and Mycology Branch, NIAID 1:05–1:30 BARDA Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria Mark Albrecht, Branch Chief, Anti-Bacterial Program, Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)
|
From page 355... ...
11:55–12:20 CDC Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria Michael Craig, Senior Advisor for Antibiotic Resistance, Antibiotic Resistance Coordination and Strategy Unit, Centers for Disease Control and Prevention 12:20–12:45 Department of Defense Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria Paige Waterman, CARB Task Force Lead, Walter Reed Army Institute of Research, Department of Defense 12:45–1:30 Q&A 1:30 Adjourn September 25, 2020 CLOSED SESSION Full Schedule in Eastern Time 11:00–1:30 Closed session for committee deliberations. 1:30 Adjourn
|
From page 356... ...
356 COMBATING AMR AND PROTECTING THE MIRACLE OF MODERN MEDICINE November 9, 2020 OPEN SESSION Full Schedule in Eastern Time 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:35 Additional Federal Actions Needed to Determine Magnitude and Reduce Impact of Antibiotic Resistance Timothy Persons, Chief Scientist and Managing Director, Science, Technology Assessment, and Analytics, Government Accountability Office Mary Denigan-Macauley, Director, Health Care, Public Health & Private Markets, Government Accountability Office 11:35–12:05 Convergence in Antimicrobial Use and Factor Influencing Resistance Ramanan Laxminarayan, Director and Senior Fellow, Cen ter for Disease Dynamics, Economics & Policy 12:05–12:15 Break 12:15–12:45 Measuring the Impacts of FDA's Actions to Promote Judicious Antimicrobial Use in Veterinary Medicine Susan Bright, Veterinary Medical Officer, Office of Surveillance & Compliance, Center for Veterinary Medicine, FDA 12:45–1:15 National Scale Monitoring of Antimicrobial Resistance in Surface Water Jay Garland, Senior Research Scientist, Office of Research and Development, Environmental Protection Agency 1:15–1:45 International Activities in AMR, Department of Health and Human Services Lynn Filpi, AMR Team Lead, Senior Global Health Officer, Pandemic and Emerging Threat Office, Office of Global Affairs, HHS 1:45–2:00 Closing Questions 2:00 Adjourn
|
From page 357... ...
Cabello, Professor Emeritus, Department of Microbiology and Immunology, New York Medical College 1:45–2:00 Closing Questions 2:00 Adjourn
|
From page 358... ...
358 COMBATING AMR AND PROTECTING THE MIRACLE OF MODERN MEDICINE November 11, 2020 OPEN SESSION Full Schedule in Eastern Time 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:35 The Global Antibiotic-Resistance Surveillance System Carmem L Pessoa-Silva, Unit Head -- Surveillance, Evidence and Laboratory Strengthening, AMR Division, WHO 11:35–12:05 Shaping Strategies for Prevention and Response to Antibiotic Resistance Tim Jinks, Head Drug-Resistant Infections Priority Program, Wellcome Trust 12:05–12:15 Break 12:15–12:45 The Fleming Fund Support for AMR Surveillance Tom Pilcher, Head of Country Coordination, The Fleming Fund, Department of Health and Social Care Claire Gordon, Lead Clinical Microbiologist, Mott MacDonald/The Fleming Fund 12:45–1:15 The Bill & Melinda Gates Foundation's Strategy in AMR Padmini Srikantiah, Senior Program Officer, Global Health Antimicrobial Resistance Strategy Lead, Bill & Melinda Gates Foundation 1:45–2:00 Questions and Discussion 2:00 Adjourn November 13, 2020 CLOSED SESSION Full Schedule in Eastern Time 11:00–12:30 Debrief on Presentations Guy Palmer, Committee Chair 12:30–1:30 Next Steps Guy Palmer, Committee Chair 1:30 Adjourn
|
From page 359... ...
Mark Albrecht, Branch Chief, Anti-Bacterial Program, Division of CBRN Countermeasures, BARDA 1:45–2:10 Championing Patient and Public Health Needs: IDSA Efforts to Strengthen the Antibiotic Pipeline Helen Boucher, Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center Director, Levy Center for Integrated Management of Antimicrobial Resistance Treasurer, Infectious Diseases Society of America 2:10–2:35 A New, Sustainable Model for Antibiotic R&D Brad Spellberg, Chief Medical Officer, Los Angeles County-University of Southern California Medical Center
|
From page 360... ...
1:15–1:30 Break 1:30–1:50 VetCAST Susceptibility Test Breakpoints Peter Panduro Damborg, Associate Professor, Veterinary Clinical Microbiology, University of Copenhagen 1:50–2:10 Addressing Challenges in Veterinary Diagnostics Brian Lubbers, Associate Professor, College of Veterinary Medicine, Kansas State University
|
From page 361... ...
APPENDIX C 361 2:10–2:45 Discussion on Veterinary Diagnostics and Susceptibility Test Breakpoints Emmanuel Okello, Moderator Peter Panduro Damborg, Associate Professor, Veterinary Clinical Microbiology, University of Copenhagen Brian Lubbers, Associate Professor, College of Veterinary Medicine, Kansas State University 2:45 Adjourn January 7, 2021 OPEN SESSION Antimicrobial Stewardship Full Schedule in Eastern Time 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:30 Telehealth and Antimicrobial Stewardship John Lynch, Associate Medical Director, Harborview Medical Center Antimicrobial Stewardship Program; Associate Professor, Division of Allergy and Infectious Diseases, University of Washington School of Medicine 11:30–11:55 Antimicrobial Stewardship in Remote Areas Marc Mendelson, Professor of Infectious Disease, Division of Infectious Diseases & HIV Medicine, University of Cape Town 11:55–12:20 Antimicrobial Stewardship in Nursing Homes: Barriers and Opportunities Chris Crnich, Chief of Medicine, Madison VA Hospital; Associate Professor of Medicine, Division of Infectious Diseases, University of Wisconsin School of Medicine and Public Health 12:20–12:35 Break 12:35–1:00 The Road to Research and Development of Alternatives to Antibiotics in the United States Cyril Gay, Senior National Program Leader, Animal Production and Protection, Agricultural Research Service, USDA
|
From page 362... ...
362 COMBATING AMR AND PROTECTING THE MIRACLE OF MODERN MEDICINE 1:00–2:30 Panel Discussion on Incentives for Stewardship in Agribusiness Marta Gomez-Chiarri, Moderator Bruce Stewart-Brown, Senior Vice-President of Food Safety, Quality, and Live Operations, Perdue Foods Bill Keleher, President and Chief Executive Officer, Kennebec River Biosciences Craig Wilson, Vice President, GMM, Costco Wholesale Heather Fowler, Director of Producer and Public Health, National Pork Board 2:30 Adjourn January 8, 2021 OPEN SESSION Full Schedule in Eastern Time 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:35 Anthropology of Antimicrobial Resistance Clare Chandler, Professor in Medical Anthropology; Director, London School of Hygiene & Tropical Medicine 11:35–12:05 The Global Burden of Antimicrobial Resistance Chris Murray, Director, Institute for Health Metrics and Evaluation; Chair and Professor, Health Metrics Sciences, University of Washington 12:05 Open Session Adjourn CLOSED SESSION Full Schedule in Eastern Time 12:05–12:20 Break 12:20–1:20 Debrief Guy Palmer, Committee Chair 1:20–2:00 Next Steps Guy Palmer, Committee Chair 2:00 Adjourn
|
From page 363... ...
APPENDIX C 363 March 16, 2021 OPEN SESSION 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:35 GARDP and Antimicrobial Development Manica Balasegaram, Executive Director, Global Antibiotic R&D Partnership Jennifer Schneider, Senior Advisor External Affairs, Global Antibiotic R&D Partnership 11:35–12:05 Inpatient Reimbursement and the Antimicrobial Market Anand Shah, former Deputy Commissioner for Medical and Scientific Affairs, FDA 12:05 Adjourn Open Session March 16, 2021 CLOSED SESSION 12:15–12:30 Overview Draft Recommendations, Guidance on Writing Recommendations 12:30–3:00 Discussion of Draft Recommendations and Conclusions in Stewardship and Prevention 3:00 Adjourn March 17, 2021 CLOSED SESSION 11:00–12:00 Discussion of Draft Recommendations and Conclusions on Push and Pull Incentives 12:00–12:15 Break 12:15–2:45 Discussion of Draft Recommendations and Conclusions on Diagnostics and Related Questions 2:45 Adjourn
|
From page 364... ...
364 COMBATING AMR AND PROTECTING THE MIRACLE OF MODERN MEDICINE March 18, 2021 CLOSED SESSION 11:00–12:00 Discussion of Draft Recommendations and Conclusions on International Action 12:00–12:15 Break 12:15–2:00 Discussion Draft Recommendations and Conclusions on Health and Economic Burden 2:00 Adjourn March 19, 2021 OPEN SESSION 11:00–11:05 Welcome Guy Palmer, Committee Chair 11:05–11:45 Direct, Predictive Application of Sequencing and Informatics Gautam Dantas, Professor, Washington University School of Medicine 11:45 Adjourn Open Session March 19, 2021 CLOSED SESSION 12:00–1:00 Discussion of Draft Recommendations and Conclusions on Surveillance 1:00 Adjourn May 11, 2021 CLOSED SESSION 11:00–2:00 Deliberation on Report Recommendations 2:00 Adjourn
|
From page 365... ...
APPENDIX C 365 May 12, 2021 CLOSED SESSION 11:00–12:15 Deliberation on Report Recommendations 12:15–12:30 Break May 12, 2021 OPEN SESSION 12:30–1:30 Agencies' Progress on National Action Plan, Mixed Methods Analysis Kris Moore, Medical Director, Center for Infectious Disease Research and Policy, University of Minnesota 1:30 End Open Session May 12, 2021 CLOSED SESSION 1:30 Debrief on Presentation 2:00 Adjourn May 13, 2021 CLOSED SESSION 11:00–2:00 Deliberation on Report Recommendations 2:00 Adjourn May 14, 2021 CLOSED SESSION 11:00–2:00 Deliberation on Report Recommendations 2:00 Adjourn
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.